SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)
CUSIP: 868459108
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,572,193
- Total 13F shares
- 54,377,202
- Share change
- +193,160
- Total reported value
- $1,451,011,413
- Put/Call ratio
- 12%
- Price per share
- $26.67
- Number of holders
- 217
- Value change
- +$3,672,754
- Number of buys
- 107
- Number of sells
- 104
Quarterly Holders Quick Answers
What is CUSIP 868459108?
CUSIP 868459108 identifies SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 868459108:
Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
15%
|
8,872,052
|
$273,171,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.5%
|
5,484,424
|
$168,865,000 | — | 30 Jun 2021 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
5.8%
|
3,324,000
|
$102,346,000 | — | 30 Jun 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
4%
|
2,276,185
|
$70,086,000 | — | 30 Jun 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
3.7%
|
2,135,923
|
$65,765,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
3.2%
|
1,827,480
|
$56,268,000 | — | 30 Jun 2021 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
2.8%
|
1,619,065
|
$49,851,000 | — | 30 Jun 2021 | |
| GW&K Investment Management, LLC |
13F
|
Company |
2.8%
|
1,616,100
|
$49,760,000 | — | 30 Jun 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.6%
|
1,516,222
|
$46,684,000 | — | 30 Jun 2021 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
2.2%
|
1,245,329
|
$38,344,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
2.2%
|
1,240,095
|
$38,182,000 | — | 30 Jun 2021 | |
| Aristotle Capital Boston, LLC |
13F
|
Company |
1.8%
|
1,061,653
|
$32,688,000 | — | 30 Jun 2021 | |
| ASHFORD CAPITAL MANAGEMENT INC |
13F
|
Company |
1.7%
|
1,000,972
|
$30,820,000 | — | 30 Jun 2021 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
1.6%
|
922,859
|
$28,415,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
905,691
|
$27,886,000 | — | 30 Jun 2021 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
1.4%
|
816,731
|
$25,147,000 | — | 30 Jun 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.4%
|
803,241
|
$24,732,000 | — | 30 Jun 2021 | |
| Invesco Ltd. |
13F
|
Company |
1.3%
|
758,403
|
$23,352,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
674,248
|
$20,761,000 | — | 30 Jun 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.1%
|
638,878
|
$19,671,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.1%
|
609,294
|
$18,760,000 | — | 30 Jun 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
607,393
|
$18,702,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
582,046
|
$17,920,000 | — | 30 Jun 2021 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0.99%
|
567,929
|
$17,485,000 | — | 30 Jun 2021 | |
| Atle Fund Management AB |
13F
|
Company |
0.92%
|
530,000
|
$16,319,000 | — | 30 Jun 2021 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
0.91%
|
522,260
|
$16,080,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.81%
|
466,073
|
$14,351,000 | — | 30 Jun 2021 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.79%
|
453,613
|
$13,967,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.73%
|
418,540
|
$12,887,000 | — | 30 Jun 2021 | |
| NORGES BANK |
13F
|
Company |
0.72%
|
413,763
|
$12,740,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.7%
|
404,523
|
$12,456,000 | — | 30 Jun 2021 | |
| Bruce & Co., Inc. |
13F
|
Company |
0.7%
|
402,105
|
$12,380,000 | — | 30 Jun 2021 | |
| SCOUT INVESTMENTS, INC. |
13F
|
Company |
0.66%
|
379,436
|
$11,683,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.64%
|
369,628
|
$11,381,000 | — | 30 Jun 2021 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.64%
|
366,895
|
$11,297,000 | — | 30 Jun 2021 | |
| S&T BANK/PA |
13F
|
Company |
0.55%
|
318,682
|
$9,813,000 | — | 30 Jun 2021 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.55%
|
316,301
|
$9,739,000 | — | 30 Jun 2021 | |
| Tributary Capital Management, LLC |
13F
|
Company |
0.52%
|
301,139
|
$9,272,000 | — | 30 Jun 2021 | |
| CONGRESS ASSET MANAGEMENT CO |
13F
|
Company |
0.51%
|
294,781
|
$9,076,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.46%
|
263,129
|
$8,103,000 | — | 30 Jun 2021 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.44%
|
252,968
|
$7,789,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.44%
|
251,356
|
$7,739,000 | — | 30 Jun 2021 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.42%
|
244,433
|
$7,526,000 | — | 30 Jun 2021 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.35%
|
202,436
|
$6,233,000 | — | 30 Jun 2021 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.35%
|
201,488
|
$6,204,000 | — | 30 Jun 2021 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.35%
|
198,948
|
$6,128,000 | — | 30 Jun 2021 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.34%
|
193,700
|
$5,964,000 | — | 30 Jun 2021 | |
| Foundry Partners, LLC |
13F
|
Company |
0.32%
|
185,905
|
$5,724,000 | — | 30 Jun 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.29%
|
165,204
|
$5,087,000 | — | 30 Jun 2021 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.28%
|
160,050
|
$4,928,000 | — | 30 Jun 2021 |
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q3 2021
As of 30 Sep 2021,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) was held by
217 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,377,202 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, DIMENSIONAL FUND ADVISORS LP, MACQUARIE GROUP LTD, STATE STREET CORP, LOOMIS SAYLES & CO L P, GW&K Investment Management, LLC, RENAISSANCE TECHNOLOGIES LLC, and Aristotle Capital Boston, LLC.
This page lists
217
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
222
Q3 2021 holders
217
Holder diff
-5
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.